1998-2022 ChinaKaoyan.com Network Studio. All Rights Reserved. 沪ICP备12018245号
分类:导师信息 来源:中国考研网 2016-07-19 相关院校:中国药科大学
李泰明,女,博士,副教授,生物制药教研室主任,药大工作24年,日本进修1年。承担多项国家课题,获得国家、省级奖励多项。发表文章:60多篇,专利10多项,出版教材多本。
①本人研究方向:
1.对糖尿病及其并发症有治疗作用的功能肽研究及新型肽疫苗设计。
2.基因工程技术构建融合蛋白药物及其发酵分离纯化质量控制研究。
②研究成果
代表文章
1.Taiming Li1*(通讯作者). Enhanced antitumor efficacy by combination treatment with a human umbilical vein endothelial cell vaccine and a tumor cell lysate-based vaccine。Tumour Biol. 2013 Oct;34(5):3173-82. SCI
2.Taiming Li*(通讯作者)Improved efficacy of therapeutic vaccination with viable human umbilical vein endothelial cells against murine melanoma by introduction of OK432 as adjuvant.Tumour Biol. 2013 Jun;34(3):1399-408. SCI
3. Taiming L. *(通讯作者)Generation of a Chimeric Plasmin-Resistant Vegf165/Vegf183 (132-158) Protein and its Comparative Activity. Protein Pept Lett. 2013 Aug;20(8):947-54.
4.Taiming Li1*(通讯作者).Immunization with P277 induces vascular leak syndrome in C57BL/6 mice via endothelial damage。Autoimmunity 2010, 43(8)8:654-663 SCI
5.Taiming Li1*(通讯作者).Specific Antibodies Elicited by a Novel DNA Vaccine Targeting Gastrin-Releasing Peptide Inhibit Murine Melanoma Growth In Vivo. American Society for Microbiology. 。Clinical and Vaccine Immunology, 2009,16(7): 1033–1039 SCI
6.Taiming Li1*(通讯作者).Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms. Immunology Letters 2009, 125:40–45 SCI
7.Taiming Li1*(通讯作者).Construction, Expression, Purification and Immunology Effect of an Anti-Atherosclerosis Chimeric Enzyme Vaccine in Escherichia coli。Immunology Letters 2009, 125:40–4。P rotein & Peptide Letters,2008, 15:7 SCI
8.Taiming Li*(通讯作者).Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain。Regulatory Peptides. 2009,157(1-3). SCI
9.Taiming Li*(通讯作者)Quantification of recombinant human relaxin-2 (B-29/A-24) in non-pregnant rat plasma using ultra performance liquid chromatography-mass spectrometry Anal. Methods, 2014,SCI
10.李泰明(第一作者)Cloning, expressing of exendin-4 analogue and bioactivity analysis in vivo. Sheng Wu Gong Cheng Xue Bao. 2012 Jul;28(7):877-86
12. 李泰明(通讯作者)Protective antitumor immunity induced by tumor cell lysates conjugated with。diphtheria toxin and adjuvant epitope in mouse breast tumor model. Chinese Journal of Cancer,2012; 31(6),295-305
出版教材
《生物制药技术》2003化学工业出版社。第一版,人民卫生出版社(国家“十一五”规划教材)
《生物工程》2009中国医药科技出版社。第一版,(规划教材)
《分子生物学实验与指导》2003中国医药科技出版社第一版,(规划教材)
《生物制药工艺学实验与指导》2008中国医药科技出版社。第一版,(规划教材)
专利10多项
1.李泰明(第一)。一种Exendin-4类似物。2013授权
2.李泰明(第一);一种具有降血糖作用的新型肽。201310193522.3公开
3.李泰明(第一)。一种Exendin-4类似物及其制备方法和应用.2013公开
4.李泰明(第一)一种人胰高血糖素样肽-2(1-35肽)类似物制备方法。2011公开CN102190720A
5.李泰明(第一)人胰高血糖素相关肽-1类似物2012公开CN102796192A.
6.李泰明(第一)一种新型血管内皮细胞疫苗及其制备方法。2012公开CN102793914A.
7.李泰明(第二)人胰高血糖素相关肽-2类似物。授权专利号ZL200510039265.2008授权
③联系方式
Address:School of Biopharmaceutics,
China Pharmaceutical University
24# TongJiaXiang Nanjing
210009P,R.China
Tel:13337717730
E-mail:taimingli@163.com
扫码关注
考研信息一网打尽